1	Varón	varón	NCMS000	C0086582	hallazgo#estructura_corporal	0-5	264_QUEST_clinical_caseMIR	SENT1	-	-
2	homosexual	homosexual	AQ0CS0	C0019900	hallazgo	6-16	264_QUEST_clinical_caseMIR	SENT1	-	-
3	de	de	SPS00	C0332285	atributo	17-19	264_QUEST_clinical_caseMIR	SENT1	-	-
4	30	30		-	-	20-22	264_QUEST_clinical_caseMIR	SENT1	-	-
5	años	año	NCMP000	C0439234	calificador	23-27	264_QUEST_clinical_caseMIR	SENT1	-	-
6	de	de	SPS00	C0001779_1	entidad_observable_1	28-30	264_QUEST_clinical_caseMIR	SENT1	-	-
7	edad	edad	NCFS000	C0001779_2	entidad_observable_2	31-35	264_QUEST_clinical_caseMIR	SENT1	-	-
8	VIH	virus_de_la_inmunodeficiencia_humana	NC00YL0	C0458074#C0019682_1	entidad_observable#organismo_1	36-39	264_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
9	(	(	Fpa	-	-	40-41	264_QUEST_clinical_caseMIR	SENT1	-	-
10	+	+	Fz	-	-	41-42	264_QUEST_clinical_caseMIR	SENT1	-	-
11	)	)	Fpt	-	-	42-43	264_QUEST_clinical_caseMIR	SENT1	-	-
12	que	que	PR0CN000	-	-	44-47	264_QUEST_clinical_caseMIR	SENT1	-	-
13	participa	participar	VMIP3S0	-	-	48-57	264_QUEST_clinical_caseMIR	SENT1	-	-
14	como	como	CS	C0332257	calificador	58-62	264_QUEST_clinical_caseMIR	SENT1	-	-
15	voluntario	voluntario	AQ0MS0	C0439656	calificador	63-73	264_QUEST_clinical_caseMIR	SENT1	-	-
16	en	en	SPS00	C1720294#C0332285	calificador#atributo	74-76	264_QUEST_clinical_caseMIR	SENT1	-	-
17	un	un		C0205447_1	calificador_1	77-79	264_QUEST_clinical_caseMIR	SENT1	-	-
18	centro	centro	NCMS000	C0205099	calificador	80-86	264_QUEST_clinical_caseMIR	SENT1	-	-
19	de	de	SPS00	C0332285	atributo	87-89	264_QUEST_clinical_caseMIR	SENT1	-	-
20	ayuda	ayuda	NCFS000	C0449435	atributo	90-95	264_QUEST_clinical_caseMIR	SENT1	-	-
21	a	a	SPS00	-	-	96-97	264_QUEST_clinical_caseMIR	SENT1	-	-
22	pacientes	paciente	NCCP000	C0030705	persona	98-107	264_QUEST_clinical_caseMIR	SENT1	-	-
23	con	con	SPS00	C0332287	atributo	108-111	264_QUEST_clinical_caseMIR	SENT1	-	-
24	SIDA	sida	NC00SC0	C0001175	trastorno	112-116	264_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
25	.	.	Fp	-	-	116-117	264_QUEST_clinical_caseMIR	SENT1	-	-

1	Según	según	SPS00	-	-	118-123	264_QUEST_clinical_caseMIR	SENT2	-	-
2	su	su	DP3CS0	-	-	124-126	264_QUEST_clinical_caseMIR	SENT2	-	-
3	historia	historia	NCFS000	-	-	127-135	264_QUEST_clinical_caseMIR	SENT2	-	-
4	clínica	clínico	AQ0FS0	C0205210	calificador	136-143	264_QUEST_clinical_caseMIR	SENT2	-	-
5	recibió	recibir	VMIS3S0	-	-	144-151	264_QUEST_clinical_caseMIR	SENT2	-	-
6	toxoide	toxoide	NCMS000	C0012551_1	sustancia_1	152-159	264_QUEST_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
7	diftérico	diftérico	AQ0MS0	C0012551_2	sustancia_2	160-169	264_QUEST_clinical_caseMIR	SENT2	I-Grp_Medicamento	-
8	(	(	Fpa	-	-	170-171	264_QUEST_clinical_caseMIR	SENT2	-	-
9	Td	td	NC00YL0	-	-	171-173	264_QUEST_clinical_caseMIR	SENT2	-	-
10	)	)	Fpt	-	-	173-174	264_QUEST_clinical_caseMIR	SENT2	-	-
11	hace	hacer	VMIP3S0	-	-	175-179	264_QUEST_clinical_caseMIR	SENT2	-	-
12	6	6		-	-	180-181	264_QUEST_clinical_caseMIR	SENT2	-	-
13	años	año	NCMP000	C0439234	calificador	182-186	264_QUEST_clinical_caseMIR	SENT2	-	-
14	,	,	Fc	-	-	186-187	264_QUEST_clinical_caseMIR	SENT2	-	-
15	la	el	DA0FS0	-	-	188-190	264_QUEST_clinical_caseMIR	SENT2	-	-
16	vacuna	vacuna	NCFS000	C0042210	producto#sustancia	191-197	264_QUEST_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
17	triple	triple	AQ0CS0	C0205174	calificador	198-204	264_QUEST_clinical_caseMIR	SENT2	I-Grp_Medicamento	-
18	vírica	vírico	AQ0FS0	C0042776	organismo	205-211	264_QUEST_clinical_caseMIR	SENT2	I-Grp_Medicamento	-
19	en	en	SPS00	C1720294#C0332285	calificador#atributo	212-214	264_QUEST_clinical_caseMIR	SENT2	-	-
20	la	el	DA0FS0	-	-	215-217	264_QUEST_clinical_caseMIR	SENT2	-	-
21	infancia	infancia	NCFS000	C0231335	calificador	218-226	264_QUEST_clinical_caseMIR	SENT2	-	-
22	y	y	CC	C1706368	calificador	227-228	264_QUEST_clinical_caseMIR	SENT2	-	-
23	en	en	SPS00	C1720294#C0332285	calificador#atributo	229-231	264_QUEST_clinical_caseMIR	SENT2	-	-
24	la	el	DA0FS0	-	-	232-234	264_QUEST_clinical_caseMIR	SENT2	-	-
25	adolescencia	adolescencia	NCFS000	C0001578#C0087178	calificador#función	235-247	264_QUEST_clinical_caseMIR	SENT2	-	-
26	,	,	Fc	-	-	247-248	264_QUEST_clinical_caseMIR	SENT2	-	-
27	y	y	CC	C1706368	calificador	249-250	264_QUEST_clinical_caseMIR	SENT2	-	-
28	la	el	DA0FS0	-	-	251-253	264_QUEST_clinical_caseMIR	SENT2	-	-
29	hepatitis	hepatitis	NCFN000	C0019163_1	trastorno_1	254-263	264_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
30	B	b	NCFS000	C0019163_2	trastorno_2	264-265	264_QUEST_clinical_caseMIR	SENT2	B-Calificador	-
31	hace	hacer	VMIP3S0	-	-	266-270	264_QUEST_clinical_caseMIR	SENT2	-	-
32	3	3		-	-	271-272	264_QUEST_clinical_caseMIR	SENT2	-	-
33	años	año	NCMP000	C0439234	calificador	273-277	264_QUEST_clinical_caseMIR	SENT2	-	-
34	.	.	Fp	-	-	277-278	264_QUEST_clinical_caseMIR	SENT2	-	-

1	Actualmente	actualmente	RG	C0521116	calificador	279-290	264_QUEST_clinical_caseMIR	SENT3	-	-
2	se	se	P00CN000	-	-	291-293	264_QUEST_clinical_caseMIR	SENT3	-	-
3	encuentra	encontrar	VMIP3S0	-	-	294-303	264_QUEST_clinical_caseMIR	SENT3	-	-
4	asintomático	asintomático	AQ0MS0	-	-	304-316	264_QUEST_clinical_caseMIR	SENT3	-	-
5	con	con	SPS00	C0332287	atributo	317-320	264_QUEST_clinical_caseMIR	SENT3	-	-
6	un	un		C0205447_1	calificador_1	321-323	264_QUEST_clinical_caseMIR	SENT3	-	-
7	recuento	recuento	NCMS000	-	-	324-332	264_QUEST_clinical_caseMIR	SENT3	-	-
8	de	de	SPS00	C0332285	atributo	333-335	264_QUEST_clinical_caseMIR	SENT3	-	-
9	CD4	CD4		-	-	336-339	264_QUEST_clinical_caseMIR	SENT3	-	-
10	superior	superior	AQ0CS0	C1282910	calificador	340-348	264_QUEST_clinical_caseMIR	SENT3	-	-
11	a	a	SPS00	-	-	349-350	264_QUEST_clinical_caseMIR	SENT3	-	-
12	200	200		-	-	351-354	264_QUEST_clinical_caseMIR	SENT3	-	-
13	cls	cls	NCCS000	-	-	355-358	264_QUEST_clinical_caseMIR	SENT3	-	-
14	/	/	Fh	-	-	358-359	264_QUEST_clinical_caseMIR	SENT3	-	-
15	μl	μl	NCMS000	-	-	359-361	264_QUEST_clinical_caseMIR	SENT3	-	-
16	.	.	Fp	-	-	361-362	264_QUEST_clinical_caseMIR	SENT3	-	-

1	¿	¿	Fia	-	-	363-364	264_QUEST_clinical_caseMIR	SENT4	-	-
2	Qué	qué	DT0CN0	-	-	364-367	264_QUEST_clinical_caseMIR	SENT4	-	-
3	vacunas	vacuna	NCFP000	C0042210	producto#sustancia	368-375	264_QUEST_clinical_caseMIR	SENT4	B-Grp_Medicamento	-
4	deberíamos	deber	VMIC1P0	-	-	376-386	264_QUEST_clinical_caseMIR	SENT4	-	-
5	recomendar	recomendar	VMN0000	-	-	387-397	264_QUEST_clinical_caseMIR	SENT4	-	-
6	le	le	PP3CSD00	C1292157#C0409974	hallazgo#trastorno	397-399	264_QUEST_clinical_caseMIR	SENT4	-	-
7	?	?	Fit	-	-	399-400	264_QUEST_clinical_caseMIR	SENT4	-	-
8	:	:	Fd	-	-	400-401	264_QUEST_clinical_caseMIR	SENT4	-	-
9	.	.	Fp	-	-	401-402	264_QUEST_clinical_caseMIR	SENT4	-	-

